Recro Pharma to Host Analyst and Investor Day on February 28, 2018
February 21, 2018 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
Recro Pharma Announces Publication of Supportive Phase II IV Meloxicam Bunionectomy Data in the Journal of Pain Research
February 20, 2018 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
Recro Pharma Announces Key Sales Team Additions
February 02, 2018 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
Recro Pharma Announces Publication of Supportive Phase II IV Meloxicam Data in the Journal of Clinical Pharmacology
January 17, 2018 08:45 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
UPDATE – Recro Pharma Announces Key Executive Promotions to the Financial Team
January 03, 2018 11:16 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
Recro Pharma Announces Key Executive Promotions to the Financial Team
January 03, 2018 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
Recro Pharma Reports Inducement Grants for New Staff
December 29, 2017 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
Recro Pharma Secures $100 Million Credit Facility
November 20, 2017 07:00 ET
|
Recro Pharma, Inc.
Proceeds Provide Funding for IV Meloxicam 30mg Approval Milestone Interest-only Structure Allows for Reinvestment of CDMO Cash Flows in Value Accretive Commercial Activities Substantial Reduction in...
Recro Pharma Reports Third Quarter 2017 Financial Results
November 09, 2017 07:00 ET
|
Recro Pharma, Inc.
NDA Submission for IV Meloxicam Accepted by U.S. FDA for Review; PDUFA Date Set for May 26, 2018 Strong Gainesville Manufacturing Performance; Third Quarter 2017 Revenues of $17.1 Million MALVERN,...
Recro Pharma to Present at Upcoming Investor Conferences
November 08, 2017 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...